Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Mirum Pharmaceuticals, Inc. | Chief Medical Officer | Common Stock | 45.8K | $1.29M | $28.04 | Nov 10, 2021 | Direct |
Jasper Therapeutics, Inc. | Chief Medical Officer | Voting Common Stock | 400 | $1.67K | $4.17 | Jun 7, 2024 | Direct |
Jasper Therapeutics, Inc. | Chief Medical Officer | Stock Option (right to buy) | 45K | Feb 15, 2024 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
JSPR | Jasper Therapeutics, Inc. | Jun 7, 2024 | 1 | $1.67K | 4 | Jun 10, 2024 | Chief Medical Officer |
JSPR | Jasper Therapeutics, Inc. | Feb 15, 2024 | 1 | $0 | 4 | Feb 20, 2024 | Chief Medical Officer |
JSPR | Jasper Therapeutics, Inc. | Jun 12, 2023 | 1 | $0 | 4 | Jun 13, 2023 | Chief Medical Officer |
JSPR | Jasper Therapeutics, Inc. | Jun 12, 2023 | 0 | $0 | 3 | Jun 13, 2023 | Chief Medical Officer |
MIRM | Mirum Pharmaceuticals, Inc. | Nov 10, 2021 | 1 | $946 | 4 | Nov 15, 2021 | Chief Medical Officer |
MIRM | Mirum Pharmaceuticals, Inc. | Sep 29, 2021 | 2 | -$26.3K | 4 | Oct 1, 2021 | Chief Medical Officer |
MIRM | Mirum Pharmaceuticals, Inc. | May 10, 2021 | 1 | $21.7K | 4 | May 12, 2021 | Chief Medical Officer |